Dupont Capital Management’s Medtronic MDT Stock Holding History

Dupont Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-71,252	Closed	-$6.17M	–	76
2026 Q1	$6.17M	Hold	71,252	–	–	0.7%	52
2025 Q4	$6.84M	Hold	71,252	–	–	0.77%	51
2025 Q3	$6.79M	Hold	71,252	–	–	0.7%	54
2025 Q2	$6.21M	Buy	+71,252	New	+$6.04M	0.67%	58
2023 Q1	–	Sell	-4,038	Closed	-$314K	–	1021
2022 Q4	$314K	Sell	4,038 -58	-1%	-$4.7K	0.01%	667
2022 Q3	$331K	Sell	4,096 -10,200	-71%	-$917K	0.02%	740
2022 Q2	$1.28M	Sell	14,296 -313	-2%	-$31.7K	0.06%	352
2022 Q1	$1.62M	Sell	14,609 -2,870	-16%	-$303K	0.07%	297
2021 Q4	$1.81M	Sell	17,479 -7,719	-31%	-$894K	0.06%	305
2021 Q3	$3.16M	Sell	25,198 -11,916	-32%	-$1.54M	0.1%	202
2021 Q2	$4.61M	Buy	37,114 +270	+0.7%	+$33.9K	0.11%	148
2021 Q1	$4.35M	Sell	36,844 -15,924	-30%	-$1.87M	0.1%	150
2020 Q4	$6.18M	Sell	52,768 -15,424	-23%	-$1.7M	0.13%	124
2020 Q3	$7.09M	Sell	68,192 -4,777	-7%	-$480K	0.16%	117
2020 Q2	$6.69M	Sell	72,969 -36,560	-33%	-$3.51M	0.15%	125
2020 Q1	$9.88M	Buy	109,529 +11,364	+12%	+$1.21M	0.24%	72
2019 Q4	$11.1M	Buy	98,165 +17,083	+21%	+$1.87M	0.25%	67
2019 Q3	$8.81M	Buy	81,082 +5,871	+8%	+$613K	0.2%	83
2019 Q2	$7.33M	Sell	75,211 -2,239	-3%	-$204K	0.17%	112
2019 Q1	$7.05M	Buy	77,450 +4,304	+6%	+$385K	0.16%	116
2018 Q4	$6.65M	Buy	73,146 +37,252	+104%	+$3.48M	0.16%	113
2018 Q3	$3.53M	Buy	35,894 +19,130	+114%	+$1.77M	0.08%	245
2018 Q2	$1.44M	Buy	16,764 +6,325	+61%	+$528K	0.03%	456
2018 Q1	$837K	Sell	10,439 -6,961	-40%	-$574K	0.02%	561
2017 Q4	$1.41M	Sell	17,400 -42,630	-71%	-$3.41M	0.03%	443
2017 Q3	$4.67M	Sell	60,030 -14,022	-19%	-$1.16M	0.11%	193
2017 Q2	$6.57M	Buy	74,052 +16,562	+29%	+$1.4M	0.15%	138
2017 Q1	$4.63M	Sell	57,490 -171,144	-75%	-$13.4M	0.1%	198
2016 Q4	$16.3M	Sell	228,634 -20,551	-8%	-$1.61M	0.36%	49
2016 Q3	$21.5M	Sell	249,185 -17,596	-7%	-$1.53M	0.48%	30
2016 Q2	$23.1M	Sell	266,781 -25,553	-9%	-$2.07M	0.52%	27
2016 Q1	$21.9M	Buy	292,334 +72,639	+33%	+$5.47M	0.5%	34
2015 Q4	$16.9M	Sell	219,695 -72,314	-25%	-$5.44M	0.41%	48
2015 Q3	$19.5M	Sell	292,009 -76,049	-21%	-$5.6M	0.49%	46
2015 Q2	$27.3M	Sell	368,058 -65,031	-15%	-$4.97M	0.59%	36
2015 Q1	$33.8M	Sell	433,089 -43,348	-9%	-$3.29M	0.66%	30
2014 Q4	$34.4M	Buy	476,437 +132,774	+39%	+$9.22M	0.63%	40
2014 Q3	$21.3M	Sell	343,663 -69,216	-17%	-$4.4M	0.37%	58
2014 Q2	$26.3M	Sell	412,879 -181,276	-31%	-$11M	0.43%	42
2014 Q1	$36.6M	Buy	594,155 +4,535	+0.8%	+$264K	0.59%	27
2013 Q4	$33.8M	Buy	589,620 +42,712	+8%	+$2.42M	0.59%	26
2013 Q3	$29.1M	Buy	546,908 +56,557	+12%	+$3.04M	0.53%	28
2013 Q2	$25.2M	Buy	+490,351	New	+$24.2M	0.47%	41

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Dupont Capital Management's MDT Position: Q2 2026 in Review

Dupont Capital Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 71,252 shares — an estimated $6.17M sold.

Dupont Capital Management first reported a position in MDT in Q2 2013 and held it in 43 quarters. The position peaked at $36.6M in Q1 2014. 1,329 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Dupont Capital Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
Dupont Capital Management sold 71,252 Medtronic shares in Q2 2026, an estimated $6.17M.
Dupont Capital Management first reported a position in Medtronic in Q2 2013 and held it in 43 quarters.
Dupont Capital Management's Medtronic position peaked at $36.6M in Q1 2014.
1,329 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Dupont Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.